NCHR Report: Breast Implant Illness — What’s the Evidence?

The National Center for Health Research report on Breast Implant Illness (BII) reviews decades of research before and after the term Breast Implant Illness became popular. Whether referred to as autoimmune symptoms, neurological symptoms, connective tissue disease, neurological symptoms, or BII, we find clear evidence of an increase in symptoms associated with breast implants, compared to women who do not have breast implants. We provide specific examples of how research that dismissed the evidence was poorly designed, often focusing on specific autoimmune diseases, only evaluated hospitalization as evidence of disease, studied women who had breast implants for a short period of time, or had other major flaws.

Read More »

Patients Continue to Be Inadequately Informed of Risk for Breast Implant-Associated ALCL

Cancer Therapy Advisor, February 8, 2021. Although the risk for breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) has been well-documented, patients considering breast implants continue to be inadequately informed of the propensity for disease development. Awareness of BIA-ALCL has risen since 2020, but adequate safeguards have not yet been put in place, according to experts in the field, including Dr. Diana Zuckerman of the National Center for Health Research and their Cancer Prevention and Treatment Fund.

Read More »